Joseph K. Belanoff
2018
In 2018, Joseph K. Belanoff earned a total compensation of $6.3M as Chief Executive Officer and President at Corcept Therapeutics, a 48% increase compared to previous year.
Compensation breakdown
Bonus | $477,750 |
---|---|
Option Awards | $5,157,075 |
Salary | $679,792 |
Total | $6,314,617 |
Belanoff received $5.2M in option awards, accounting for 82% of the total pay in 2018.
Belanoff also received $477.8K in bonus and $679.8K in salary.
Rankings
In 2018, Joseph K. Belanoff's compensation ranked 1,457th out of 14,244 executives tracked by ExecPay. In other words, Belanoff earned more than 89.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,457 | 90th |
Manufacturing | 509 | 91st |
Chemicals And Allied Products | 160 | 93rd |
Drugs | 125 | 93rd |
Pharmaceutical Preparations | 91 | 93rd |
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2018.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019